A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal Immunization.

导出 LinkOut

翻译打印收藏纠错

第一作者： Bing,Cai

第一单位： Vaccine Research and Development, Pfizer Inc., Collegeville, PA 19426, USA.

作者： Bing,Cai ^[1] ; Yili,Chen ^[2] ; Yasmeen,Agosti ^[3] ; Beate,Schmoele-Thoma ^[4] ; Kenneth,Koury ^[4] ; Kathrin U,Jansen ^[4] ; William C,Gruber ^[4] ; Philip R,Dormitzer ^[4] ; Kena A,Swanson ^[4]

作者单位： Vaccine Research and Development, Pfizer Inc., Collegeville, PA 19426, USA. ^[1] Clinical Development and Operations, Pfizer Inc., Collegeville, PA 19426, USA. ^[2] Chief Medical Affairs Office, Pfizer Inc., Collegeville, PA 19426, USA. ^[3] Vaccine Research and Development, Pfizer Inc., Pearl River, NY 10965, USA. ^[4]

关键词 RSV airway resistance infants modeling vaccine efficacy viral infection

DOI 10.3390/vaccines12121351

PMID 39772012

发布时间 2025-01-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Vaccines

2024年12卷12期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal Immunization.

Vaccines

相似文献

Vaccines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal Immunization.

Vaccines

相似文献

Vaccines

相关期刊

检索历史清除